Nearly 13.8 percent of stroke patients in India are below 45 years, with hypertension identified as the leading risk factor ...

This study aims to provide a narrative review of the influence of SES on stroke, following a timeline structure of stroke: it begins by addressing stroke occurrence, access to and quality of acute ...

Please provide your email address to receive an email when new articles are posted on . Societies issued new guidelines for the screening and treatment of stroke. The new document provides ...

As stroke risk rises for women as they age — especially after menopause — a new long-term study suggests that what they eat may play a powerful role in lowering that risk. Stroke is a leading cause of ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** CVA has introduced the Scout XP ...

Add Yahoo as a preferred source to see more of our stories on Google. Tune into The Daily Beast Podcast on Sunday, Jan. 25 at 2 p.m. when Dr. Bruce Davidson joins host Joanna Coles for a stark ...

Share on Pinterest Heart disease remains the leading cause of death in the United States, while stroke has climbed to the fourth main cause. Busà Photography/Getty Images Deaths from heart disease and ...

He was healthy and fit at 54, an avid runner with no vices — he didn’t smoke, drink or do drugs. So when he suddenly experienced left-sided weakness, numbness and difficulties with balance, walking, ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...